167843-21-2
Chemical Structure
S-18326
- CAS No.: 167843-21-2
- Formula:C23H37BN6O5
- Molecular Weight:488.39
IUPAC Name: ((6R,12R)-1-amino-12-benzyl-10-cyclopentyl-1-imino-8,11,14-trioxo-2,7,10,13-tetraazapentadecan-6-yl)boronic acid
InChIKey: XSHCQGJMSFRKKN-UXHICEINSA-N
SMILES: O=C(N(C1CCCC1)CC(N[C@@H](CCCNC(N)=N)B(O)O)=O)[C@H](NC(C)=O)CC2=CC=CC=C2
Biological Activity: S-18326 is an orally active direct thrombin inhibitor. S-18326 inhibits thrombus formation by reversibly and with high affinity binding to the active site of thrombin, directly preventing the conversion of fibrinogen to fibrin. S-18326 effectively prolongs various clotting times in human plasma. S-18326 has demonstrated antithrombotic efficacy in multiple animal models without causing thrombocytopenia. S-18326 can be used in research on thromboembolic diseases[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
S-18326 | S-18326 is an orally active direct thrombin inhibitor. S-18326 inhibits thrombus formation by reversibly and with high affinity binding to the active site of thrombin, directly preventing the conversion of fibrinogen to fibrin. S-18326 effectively prolongs various clotting times in human plasma. S-18326 has demonstrated antithrombotic efficacy in multiple animal models without causing thrombocytopenia. S-18326 can be used in research on thromboembolic diseases. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
